Picture of Biora Therapeutics logo

BIORQ — Biora Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Biora Therapeutics Inc expected to post a loss of $1.75 a share - Earnings Preview

* Biora Therapeutics Inc  BIOR.OQ   BIOR.O  is expected
to report 
results on May 8 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Biora Therapeutics
Inc is
for a loss of $1.75 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $65​, above​ its last closing price
of $2.46. ​​​

This summary was machine generated May 5 at 14:37 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Biora Therapeutics

See all news